Stay updated on Pembrolizumab and Olaparib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.
Latest updates to the Pembrolizumab and Olaparib in NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check15 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new addition was made on November 19, 2024, while a significant section detailing various data fields and download options was removed on November 6, 2024.SummaryDifference14%
- Check43 days agoChange DetectedThe website has updated to version v2.12.2, with new results posted and enhanced download options for various file formats, replacing the previous version v2.12.1 where results were only submitted.SummaryDifference17%
- Check51 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
- Check58 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.6%
Stay in the know with updates to Pembrolizumab and Olaparib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.